EUVIMEDObjevte EUVIMED
Open access

Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance

Linjia Su, Sepideh Rezaei, German Mejia, Popular Pandey, Kevin Jeanne Dit Fouque, Francisco Fernandez-Lima, Anthony McGoron, Jin He, Fenfei Leng

ChemMedChem · 2024

DOI: 10.1002/cmdc.202300481 ↗

At a glance

Journal article in ChemMedChem, 2024. Written by Linjia Su and 8 co-authors. Institution: Biomolecular Sciences Institute, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA. Major MEDLINE topics: Daunorubicin, Doxorubicin, Drug Resistance, Neoplasm, Formaldehyde. Cited 1 times so far (Crossref); 29 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Daunorubicin and doxorubicin are among the most potent anti‐cancer drugs and bind to DNA through intercalation. In this paper, we demonstrate that formaldehyde can efficiently and specifically conjugate daunorubicin and doxorubicin to GTP, resulting in the formation of daunorubicin‐GTP‐1 and doxorubicin‐GTP‐1 conjugates. The linkage occurs between the 2‐NH 2 of guanine and the 3’‐NH 2 of daunosamine. We characterized these daunorubicin/doxorubicin‐GTP conjugates using various methods, including UV‐Vis, fluorescence, CD, FT‐IR, and mass spectrometry. Our results also indicate that these daunorubicin/doxorubicin‐GTP conjugates bind to DNA via intercalation. Furthermore, we observed rapid accumulation of these conjugates in human cancer cells and observed cytotoxic effects in both doxorubicin‐sensitive SK‐OV‐3 and doxorubicin‐resistant NCI/ADR‐RES cells, suggesting that these daunorubicin and doxorubicin derivatives can overcome doxorubicin resistance.

Subjects

MeSH terms (MEDLINE)

DaunorubicinDoxorubicinDrug Resistance, NeoplasmFormaldehydeHumansCell Line, TumorGuanosine TriphosphateAntibiotics, AntineoplasticDNA

Author keywords

And formaldehydeDaunorubicinDoxorubicinGTPThe daunorubicin-GTP-1 conjugateThe doxorubicin-GTP-1 conjugate

Substances

DaunorubicinDoxorubicinFormaldehydeGuanosine TriphosphateAntibiotics, AntineoplasticDNA

Authors and institutions

  • Biomolecular Sciences Institute, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA.
  • Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA.
  • Department of Physics, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA.
  • Department of Biomedical Engineering, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA.

Funding

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Su, L., Rezaei, S., Mejia, G., Pandey, P., Dit Fouque, K. J., Fernandez-Lima, F., McGoron, A., He, J., & Leng, F. (2024). Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance. ChemMedChem. https://doi.org/10.1002/cmdc.202300481

Vancouver

Su L, Rezaei S, Mejia G, Pandey P, Dit Fouque KJ, Fernandez-Lima F, et al. Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance. ChemMedChem. 2024. doi:10.1002/cmdc.202300481

BibTeX
@article{Su2024,
  author = {Su, Linjia and Rezaei, Sepideh and Mejia, German and Pandey, Popular and Dit Fouque, Kevin Jeanne and Fernandez-Lima, Francisco and McGoron, Anthony and He, Jin and Leng, Fenfei},
  title = {Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202300481}
}
Start for free →